Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease
US7456161B2 · kind B2 · utility
18Cited by
37References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 3, 2003 |
| Grant date | Nov 25, 2008 |
| Priority date | — |
| Expiry date | Jun 10, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating or preventing chronic obstructive pulmonary disease (COPD) by using as active agent a non-glucorticoid steroid, analogue thereof, such as dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S), or their salts, in an amount effective for preventing or treating COPD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.